The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

By                      

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 10-16

Spandidos Publications

Access to resources Recommend Favorite

PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

By Al-Hujaily Ensaf   Mohamed Ameera   Al-Sharif Ibtehaj   Youssef Khairia   Manogaran Pulicat   Al-Otaibi Basem   Al-Haza’a Amal   Al-Jammaz Ibrahim   Al-Hussein Khaled   Aboussekhra Abdelilah  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 97-107

Springer Publishing Company

Access to resources Recommend Favorite

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

By Huang Fang   Wu Xiao-Nan   Chen Jie   Wang Wen-Xiang   Lu ZuFu  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-06 ,pp. : 1611-1616

Spandidos Publications

Access to resources Recommend Favorite

Differentially expressed proteins in human breast cancer cells sensitive and resistant to paclitaxel

By          

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 822-830

Spandidos Publications

Access to resources Recommend Favorite

T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells

By    

International Journal of Oncology, Vol. 41, Iss. 1, 2012-01 ,pp. : 267-275

Spandidos Publications

Access to resources Recommend Favorite